Is there an advantage to combination therapy with ACE inhibitors and angiotensin II-receptor blockers?February 1, 2000Drug TherapyNephrologyVascularPreventive CareCardiology
Glycoprotein IIb/IIIa inhibitors in acute coronary syndromesFebruary 1, 2000CardiologyDrug TherapyHematologyVascular
Should patients receive anticoagulation for paroxysmal atrial fibrillation?January 1, 2000CardiologyDrug TherapyVascularPreventive Care
Heart failure: Highlights from new consensus guidelinesJanuary 1, 2000CardiologyEmergency MedicineDrug TherapyVascular
Unfractionated and low-molecular-weight heparins in acute coronary syndromes: Current recommendationsJanuary 1, 2000CardiologyCritical CareDrug TherapyEmergency MedicineHospital MedicineHematologyVascular
Aspirin, ticlopidine, and clopidogrel in acute coronary syndromes: Underused treatments could save thousands of livesNovember 1, 1999Cardiology
The pathogenesis and spectrum of acute coronary syndromes: From plaque formation to thrombosisOctober 1, 1999Cardiology
Preventive cardiology: Whose job is it? Who will pay for it? What is the best strategy?September 1, 1996Cardiology
Assessing myocardial ischemia, hibernation, and viability: Stress echocardiography and nuclear imagingMarch 1, 1995Cardiology
